Knee osteoarthritis
Not recommended
Glucosamine and chondroitin are the most-studied and most-debated osteoarthritis nutraceuticals. The independent GAIT RCT (NEJM 2006, 1,583 patients, 6 months) showed no clinically meaningful effect on pain or function versus placebo in the general population. A subgroup with moderate-to-severe pain had a modest effect from the combination. ACR 2019 strongly recommends AGAINST glucosamine and chondroitin in knee, hip, and hand osteoarthritis. OARSI 2019 gives mixed guidance – pharmaceutical glucosamine sulphate may be considered; over-the-counter glucosamine hydrochloride is not.
The distinction between pharmaceutical glucosamine sulphate (Dona, Structum) and over-the-counter glucosamine hydrochloride is important: positive RCTs mainly used the sulphate form at 1,500 mg daily.
Sources
- NEJM: Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis (GAIT) (2006)
- ACR: American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019)
- OARSI: OARSI Guidelines for the Non-Surgical Management of Knee Osteoarthritis – Glucosamine evidence summary (2019)
- Cochrane: Glucosamine therapy for treating osteoarthritis (2005)